厦门大学附属翔安医院中心实验室助理研究员，福建医师协会转化医学学组成员，硕士生导师。

目前主要从事蛋白激酶在泌尿系肿瘤进展、耐药及肿瘤血管生成中的作用及应用的相关研究。近年来主持国家自然科学基金2项，博士后基金1项，省、市级课题2项，市重点实验室开放课题1项，校级课题1项，发表SCI论文20余篇，发明专利1项。作为主要完成人获陕西省高校科学技术奖一等奖1项。

联系方式：hmsun@xah.xmu.edu.cn

代表性成果

1. Sun HM, Zheng JZ, Xiao JJ, Yue JT, Shi ZY, Xuan ZD, Chen C, Zhao Y, Tang WB, Ye SP, Li JX, Deng QM, Zhang L, Zhu F*, Shao C*. TOPK/PBK is phosphorylated by ERK2 at serine 32, promotes tumorigenesis and is involved in sorafenib resistance in RCC. Cell Death Dis. 2022 May 11; 13(5):450.

2. Zheng JZ, Shi ZY, Yang PB, Zhao Y, Tang WB, Ye SP, Xuan ZD, Chen C, Shao C, Wu QG*, Sun HM*. ERK-Smurf1-RhoA signaling is critical for TGF-drived EMT and tumor metastasis. Life Sci Alliance. 2020 Jun 2; 5(10): e202101330.

3. Shi ZY, Zheng JZ, Tang WB, Bai Y, Zhang L, Xuan ZD, Sun HM*, Shao C*. Multifunctional Nanomaterials for Ferroptotic Cancer Therapy. Front Chem. 2022 Mar 24;10:868630.

4. Xuan ZD, Chen C, Tang WB, Ye SP, Zheng JZ, Zhao Y, Shi ZY, Zhang L, Sun HM* and Shao C*. TKI-Resistant Renal Cancer Secretes Low-Level Exosomal miR-549a to Induce Vascular Permeability and Angiogenesis to Promote Tumor Metastasis. Front Cell Dev Biol. 2021 Jun 10;9:689947.

5. Shi ZY, Zhang L, Zheng JZ, Sun HM* and Shao C*. Ferroptosis: Biochemistry and Biology in Cancers. Ferroptosis: Biochemistry and Biology in Cancers. Front Oncol. 2021 Apr 1;11:579286.